Year |
Citation |
Score |
2022 |
Avanzino BC, Prabhakar K, Dalvi P, Hartstein S, Kehm H, Balasubramani A, Boudreau AA, Buelow B, Chang K, Davison LM, Iyer S, Kalwit V, Lewis Wilson K, Malik-Chaudhry HK, Pierson W, ... ... Trinklein ND, et al. A T-cell engaging bispecific antibody with a tumor-selective bivalent folate receptor alpha binding arm for the treatment of ovarian cancer. Oncoimmunology. 11: 2113697. PMID 36016696 DOI: 10.1080/2162402X.2022.2113697 |
0.385 |
|
2021 |
Dang K, Castello G, Clarke SC, Li Y, Balasubramani A, Boudreau A, Davison L, Harris KE, Pham D, Sankaran P, Ugamraj HS, Deng R, Kwek S, Starzinski A, Iyer S, ... ... Trinklein ND, et al. Attenuating CD3 affinity in a PSMAxCD3 bispecific antibody enables killing of prostate tumor cells with reduced cytokine release. Journal For Immunotherapy of Cancer. 9. PMID 34088740 DOI: 10.1136/jitc-2021-002488 |
0.317 |
|
2021 |
Malik-Chaudhry HK, Prabhakar K, Ugamraj HS, Boudreau AA, Buelow B, Dang K, Davison LM, Harris KE, Jorgensen B, Ogana H, Pham D, Schellenberger U, Van Schooten W, Buelow R, Iyer S, ... Trinklein ND, et al. TNB-486 induces potent tumor cell cytotoxicity coupled with low cytokine release in preclinical models of B-NHL. Mabs. 13: 1890411. PMID 33818299 DOI: 10.1080/19420862.2021.1890411 |
0.428 |
|
2020 |
Vafa O, Trinklein ND. Perspective: Designing T-Cell Engagers With Better Therapeutic Windows. Frontiers in Oncology. 10: 446. PMID 32351885 DOI: 10.3389/Fonc.2020.00446 |
0.472 |
|
2020 |
Lam N, Trinklein ND, Buelow B, Patterson GH, Ojha N, Kochenderfer JN. Author Correction: Anti-BCMA chimeric antigen receptors with fully human heavy-chain-only antigen recognition domains. Nature Communications. 11: 1319. PMID 32152289 DOI: 10.1038/S41467-020-15145-8 |
0.344 |
|
2020 |
Lam N, Trinklein ND, Buelow B, Patterson GH, Ojha N, Kochenderfer JN. Anti-BCMA chimeric antigen receptors with fully human heavy-chain-only antigen recognition domains. Nature Communications. 11: 283. PMID 31941907 DOI: 10.1038/S41467-019-14119-9 |
0.455 |
|
2020 |
Buelow B, Avanzino B, Balasubramani A, Boudreau A, Davison L, Ganesan P, Harris K, Hartstein S, Malik-Chaudhry H, Pham D, Prabhakar K, Rangaswamy U, Saiganesh S, Schellenberger U, Ugamraj H, ... ... Trinklein N, et al. A CD3 x FRα T-cell engaging bispecific antibody for efficient killing of ovarian cancer cells with minimal cytokine release. Journal of Clinical Oncology. 38: e18050-e18050. DOI: 10.1200/Jco.2020.38.15_Suppl.E18050 |
0.548 |
|
2019 |
Trinklein ND, Pham D, Schellenberger U, Buelow B, Boudreau A, Choudhry P, Clarke SC, Dang K, Harris KE, Iyer S, Jorgensen B, Pratap PP, Rangaswamy US, Ugamraj HS, Vafa O, et al. Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodies. Mabs. PMID 30698484 DOI: 10.1080/19420862.2019.1574521 |
0.811 |
|
2019 |
Clarke S, Dang K, Li Y, Sankaran P, Pham D, Balasubramani A, Davison L, Harris K, Jorgensen B, Schellenberger U, Trinklein N, Ugamraj H, Buelow R, Van Schooten W, Force Aldred S, et al. A novel CD3xPSMA bispecific antibody for efficient T cell mediated killing of prostate tumor cells with minimal cytokine release. Journal of Clinical Oncology. 37: 324-324. DOI: 10.1200/Jco.2019.37.7_Suppl.324 |
0.808 |
|
2019 |
Buelow B, Clarke S, Dang K, Li J, Rancan C, Li Y, Sankaran P, Pham D, Balasubramani A, Davison L, Harris K, Jorgensen B, Schellenberger U, Trinklein N, Ugamraj H, et al. Evaluation of monovalent versus biparatopic CD3xPSMA bispecific antibodies for t-cell mediated killing of prostate tumor cells with minimal cytokine release. Journal of Clinical Oncology. 37: e16519-e16519. DOI: 10.1200/Jco.2019.37.15_Suppl.E16519 |
0.809 |
|
2019 |
Mikkilineni L, Manasanch EE, Lam N, Vanasse D, Brudno JN, Maric I, Rose JJ, Stetler-Stevenson M, Wang H, Yuan CM, Stroncek DF, Mann J, Ganadan M, Patel R, Trinklein N, et al. T Cells Expressing an Anti-B-Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor with a Fully-Human Heavy-Chain-Only Antigen Recognition Domain Induce Remissions in Patients with Relapsed Multiple Myeloma Blood. 134: 3230-3230. DOI: 10.1182/Blood-2019-129088 |
0.42 |
|
2019 |
Malik H, Buelow B, Rangaswamy U, Balasubramani A, Boudreau A, Dang K, Davison L, Force Aldred S, Harris KM, Iyer S, Jorgensen B, Pham D, Prabhakar K, Schellenberger U, Ugamraj H, ... Trinklein N, et al. TNB-486, a Novel Fully Human Bispecific CD19 x CD3 Antibody That Kills CD19-Positive Tumor Cells with Minimal Cytokine Secretion Blood. 134: 4070-4070. DOI: 10.1182/Blood-2019-123226 |
0.809 |
|
2019 |
Lorentsen K, Sankaran P, Trinklein ND, Pham D, Schellenberger U, Buelow B, Boudreau A, Choudhry P, Clarke SC, Dang K, Harris KE, Iyer S, Jorgensen B, Pratap P, Rangaswamy US, et al. Abstract 1554: Uncoupling tumor-cell cytotoxicity from cytokine release with novel T-cell engaging bispecific antibodies Cancer Research. 79: 1554-1554. DOI: 10.1158/1538-7445.Am2019-1554 |
0.554 |
|
2018 |
Clarke SC, Ma B, Trinklein ND, Schellenberger U, Osborn MJ, Ouisse LH, Boudreau A, Davison LM, Harris KE, Ugamraj HS, Balasubramani A, Dang KH, Jorgensen B, Ogana HAN, Pham DT, et al. Multispecific Antibody Development Platform Based on Human Heavy Chain Antibodies. Frontiers in Immunology. 9: 3037. PMID 30666250 DOI: 10.3389/fimmu.2018.03037 |
0.761 |
|
2018 |
Harris KE, Aldred SF, Davison LM, Ogana HAN, Boudreau A, Brüggemann M, Osborn M, Ma B, Buelow B, Clarke SC, Dang KH, Iyer S, Jorgensen B, Pham DT, Pratap PP, ... ... Trinklein ND, et al. Sequence-Based Discovery Demonstrates That Fixed Light Chain Human Transgenic Rats Produce a Diverse Repertoire of Antigen-Specific Antibodies. Frontiers in Immunology. 9: 889. PMID 29740455 DOI: 10.3389/Fimmu.2018.00889 |
0.404 |
|
2018 |
Bradbury ARM, Trinklein ND, Thie H, Wilkinson IC, Tandon AK, Anderson S, Bladen CL, Jones B, Aldred SF, Bestagno M, Burrone O, Maynard J, Ferrara F, Trimmer JS, Görnemann J, et al. When monoclonal antibodies are not monospecific: hybridomas frequently express additional functional variable regions. Mabs. 1-19. PMID 29485921 DOI: 10.1080/19420862.2018.1445456 |
0.399 |
|
2018 |
Buelow B, Choudhry P, Clarke S, Dang K, Davison L, Force Aldred S, Harris K, Pham D, Pratap P, Rangaswamy U, Schellenberger U, Shah N, Trinklein N, Ugamraj H, Wiita A, et al. Development of a fully human t-cell engaging bispecific antibody for the treatment of multiple myeloma. Journal of Clinical Oncology. 36: 60-60. DOI: 10.1200/Jco.2018.36.5_Suppl.60 |
0.81 |
|
2018 |
Force Aldred S, Boudreau A, Buelow B, Clarke S, Dang K, Davison L, Harris K, Iyer S, Jorgensen B, Ogana H, Pham D, Pratap P, Rangaswamy U, Schellenberger U, Trinklein N, et al. Multispecific antibodies targeting CD38 show potent tumor-specific cytotoxicity. Journal of Clinical Oncology. 36: 57-57. DOI: 10.1200/Jco.2018.36.5_Suppl.57 |
0.792 |
|
2018 |
Rangaswamy U, Boudreau A, Buelow B, Clarke S, Dang K, Davison L, Force Aldred S, Harris K, Iyer S, Jorgensen B, Ogana H, Pham D, Pratap P, Trinklein N, Schellenberger U, et al. A novel T-cell bispecific antibody platform for efficient T-cell mediated killing of tumor cells with minimal cytokine release. Journal of Clinical Oncology. 36: 209-209. DOI: 10.1200/Jco.2018.36.5_Suppl.209 |
0.812 |
|
2018 |
Buelow B, Choudry P, Clarke S, Dang K, Davison L, Force Aldred S, Harris K, Pratap P, Pham D, Rangaswamy U, Schellenberger U, Shah N, Trinklein N, Ugamraj H, Wiita A, et al. Pre-clinical development of TNB-383B, a fully human T-cell engaging bispecific antibody targeting BCMA for the treatment of multiple myeloma. Journal of Clinical Oncology. 36: 8034-8034. DOI: 10.1200/Jco.2018.36.15_Suppl.8034 |
0.789 |
|
2018 |
Malik H, Buelow B, Avanzino B, Balasubramani A, Boudreau A, Clarke S, Dang K, Davison L, Force Aldred S, Harris K, Jorgensen B, Li Y, Medlari H, Narayan K, Ogana H, ... ... Trinklein N, et al. A Novel Fully Human Bispecific CD19 x CD3 Antibody That Kills Lymphoma Cells with Minimal Cytokine Secretion Blood. 132: 1671-1671. DOI: 10.1182/Blood-2018-99-118913 |
0.808 |
|
2017 |
Lam N, Alabanza L, Trinklein N, Buelow B, Kochenderfer JN. T Cells Expressing Anti-B-Cell Maturation Antigen (BCMA) Chimeric Antigen Receptors with Antigen Recognition Domains Made up of Only Single Human Heavy Chain Variable Domains Specifically Recognize Bcma and Eradicate Tumors in Mice Blood. 130: 504-504. DOI: 10.1182/Blood.V130.Suppl_1.504.504 |
0.497 |
|
2017 |
Buelow B, Pham D, Choudhry P, Dang K, Pratap P, Clarke S, Harris K, Jorgensen B, Aldred SF, Schellenberger U, Shah N, Trinklein N, Wiita AP, Iyer S, Schooten WV. T Cell Engagement without Cytokine Storm: A Novel Bcma x CD3 Antibody Killing Myeloma Cells with Minimal Cytokine Secretion Blood. 130: 501-501. DOI: 10.1182/Blood.V130.Suppl_1.501.501 |
0.496 |
|
2016 |
Trinklein N, Aldred SF, Schellenberger U, Harris K, Clarke S, Dang K, Pham D, Bruggemann M, Wv. Abstract LB-090: Sequence-based discovery of fully human anti-CD3 and anti-PDL1 single domain antibodies using novel transgenic rats Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-090 |
0.472 |
|
2014 |
Smith RP, Eckalbar WL, Morrissey KM, Luizon MR, Hoffmann TJ, Sun X, Jones SL, Force Aldred S, Ramamoorthy A, Desta Z, Liu Y, Skaar TC, Trinklein ND, Giacomini KM, Ahituv N. Genome-wide discovery of drug-dependent human liver regulatory elements. Plos Genetics. 10: e1004648. PMID 25275310 DOI: 10.1371/Journal.Pgen.1004648 |
0.77 |
|
2012 |
Hastak K, Adimoolam S, Trinklein ND, Myers RM, Ford JM. Identification of a Functional In Vivo p53 Response Element in the Coding Sequence of the Xeroderma Pigmentosum Group C Gene. Genes & Cancer. 3: 131-40. PMID 23050045 DOI: 10.1177/1947601912456288 |
0.532 |
|
2012 |
Whitfield TW, Wang J, Collins PJ, Partridge EC, Aldred SF, Trinklein ND, Myers RM, Weng Z. Functional analysis of transcription factor binding sites in human promoters. Genome Biology. 13: R50. PMID 22951020 DOI: 10.1186/Gb-2012-13-9-R50 |
0.521 |
|
2010 |
Landolin JM, Johnson DS, Trinklein ND, Aldred SF, Medina C, Shulha H, Weng Z, Myers RM. Sequence features that drive human promoter function and tissue specificity. Genome Research. 20: 890-8. PMID 20501695 DOI: 10.1101/Gr.100370.109 |
0.588 |
|
2009 |
Hartzell DD, Trinklein ND, Mendez J, Murphy N, Aldred SF, Wood K, Urh M. A functional analysis of the CREB signaling pathway using HaloCHIP-chip and high throughput reporter assays. Bmc Genomics. 10: 497. PMID 19860899 DOI: 10.1186/1471-2164-10-497 |
0.416 |
|
2008 |
Johnson DS, Li W, Gordon DB, Bhattacharjee A, Curry B, Ghosh J, Brizuela L, Carroll JS, Brown M, Flicek P, Koch CM, Dunham I, Bieda M, Xu X, Farnham PJ, ... ... Trinklein ND, et al. Systematic evaluation of variability in ChIP-chip experiments using predefined DNA targets. Genome Research. 18: 393-403. PMID 18258921 DOI: 10.1101/Gr.7080508 |
0.484 |
|
2007 |
Collins PJ, Kobayashi Y, Nguyen L, Trinklein ND, Myers RM. The ets-related transcription factor GABP directs bidirectional transcription. Plos Genetics. 3: e208. PMID 18020712 DOI: 10.1371/Journal.Pgen.0030208 |
0.556 |
|
2007 |
Birney E, Stamatoyannopoulos JA, Dutta A, Guigó R, Gingeras TR, Margulies EH, Weng Z, Snyder M, Dermitzakis ET, Thurman RE, Kuehn MS, Taylor CM, Neph S, Koch CM, ... ... Trinklein ND, et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature. 447: 799-816. PMID 17571346 DOI: 10.1038/Nature05874 |
0.667 |
|
2007 |
Lin JM, Collins PJ, Trinklein ND, Fu Y, Xi H, Myers RM, Weng Z. Transcription factor binding and modified histones in human bidirectional promoters. Genome Research. 17: 818-27. PMID 17568000 DOI: 10.1101/Gr.5623407 |
0.572 |
|
2007 |
Trinklein ND, Karaöz U, Wu J, Halees A, Force Aldred S, Collins PJ, Zheng D, Zhang ZD, Gerstein MB, Snyder M, Myers RM, Weng Z. Integrated analysis of experimental data sets reveals many novel promoters in 1% of the human genome. Genome Research. 17: 720-31. PMID 17567992 DOI: 10.1101/Gr.5716607 |
0.773 |
|
2007 |
Cooper SJ, Trinklein ND, Nguyen L, Myers RM. Serum response factor binding sites differ in three human cell types. Genome Research. 17: 136-44. PMID 17200232 DOI: 10.1101/Gr.5875007 |
0.647 |
|
2006 |
Cooper SJ, Trinklein ND, Anton ED, Nguyen L, Myers RM. Comprehensive analysis of transcriptional promoter structure and function in 1% of the human genome. Genome Research. 16: 1-10. PMID 16344566 DOI: 10.1101/Gr.4222606 |
0.683 |
|
2005 |
Kim TH, Barrera LO, Qu C, Van Calcar S, Trinklein ND, Cooper SJ, Luna RM, Glass CK, Rosenfeld MG, Myers RM, Ren B. Direct isolation and identification of promoters in the human genome. Genome Research. 15: 830-9. PMID 15899964 DOI: 10.1101/Gr.3430605 |
0.696 |
|
2004 |
Feingold EA, Good PJ, Guyer MS, Kamholz S, Liefer L, Wetterstrand K, Collins FS, Gingeras TR, Kampa D, Sekinger EA, Cheng J, Hirsch H, Ghosh S, Zhu Z, Patel S, ... ... Trinklein ND, et al. The ENCODE (ENCyclopedia of DNA Elements) Project Science. 306: 636-640. PMID 15499007 DOI: 10.1126/Science.1105136 |
0.746 |
|
2004 |
Trinklein ND, Chen WC, Kingston RE, Myers RM. Transcriptional regulation and binding of heat shock factor 1 and heat shock factor 2 to 32 human heat shock genes during thermal stress and differentiation. Cell Stress & Chaperones. 9: 21-8. PMID 15270074 DOI: 10.1379/1466-1268(2004)009<0021:Traboh>2.0.Co;2 |
0.495 |
|
2004 |
Murray JI, Whitfield ML, Trinklein ND, Myers RM, Brown PO, Botstein D. Diverse and specific gene expression responses to stresses in cultured human cells. Molecular Biology of the Cell. 15: 2361-74. PMID 15004229 DOI: 10.1091/Mbc.E03-11-0799 |
0.495 |
|
2004 |
Trinklein ND, Aldred SF, Hartman SJ, Schroeder DI, Otillar RP, Myers RM. An abundance of bidirectional promoters in the human genome. Genome Research. 14: 62-6. PMID 14707170 DOI: 10.1101/Gr.1982804 |
0.76 |
|
2004 |
Trinklein ND, Murray JI, Hartman SJ, Botstein D, Myers RM. The role of heat shock transcription factor 1 in the genome-wide regulation of the mammalian heat shock response. Molecular Biology of the Cell. 15: 1254-61. PMID 14668476 DOI: 10.1091/Mbc.E03-10-0738 |
0.507 |
|
2003 |
Trinklein ND, Aldred SJ, Saldanha AJ, Myers RM. Identification and functional analysis of human transcriptional promoters. Genome Research. 13: 308-12. PMID 12566409 DOI: 10.1101/Gr.794803 |
0.606 |
|
Show low-probability matches. |